Fuji to save the world!

YAY, All the more reason to buy a Fuji !!



as for Film ... my all time Favorite film was FUJI Neopan 1600
then TMax 400 & HP5
 
I used for many years almost only Fujichrome 50 and Fujichrome 100. Then I added Velvia.
 
... and the shares of Fuji stocks surge 15% today.
<https://japantoday.com/category/business/update-1-fujifilm-holdings-shares-hit-daily-limit-high-on-china-coronavirus-drug-trial-boost>
 
Avigan has been around for some time, but hasn’t been approved for general use in Japan due to concerns about side effects. The Chinese have had some success using it with the corona virus (and japan too I think) but the Koreans are being more cautious.

S. Korea not to use Japan's Avigan as coronavirus drug

https://m-en.yna.co.kr/view/AEN20200316002400320
 
jonmanjiro said:
Avigan has been around for some time, but hasn’t been approved for general use in Japan due to concerns about side effects. The Chinese have had some success using it with the corona virus (and japan too I think) but the Koreans are being more cautious.

S. Korea not to use Japan's Avigan as coronavirus drug

https://m-en.yna.co.kr/view/AEN20200316002400320
Click to expand...

The ministry also allowed a locally developed anti-viral drug called Virus Suppressing Factor (VSF) to treat COVID-19 patients at the request of Seoul National University Hospital.

hmmmm.
 
jonmanjiro said:
Avigan has been around for some time, but hasn’t been approved for general use in Japan due to concerns about side effects. The Chinese have had some success using it with the corona virus (and japan too I think) but the Koreans are being more cautious.

S. Korea not to use Japan's Avigan as coronavirus drug

https://m-en.yna.co.kr/view/AEN20200316002400320
Click to expand...

I have a feeling this have something to do with the recent political climate between the three countries.
 
Huss said:
The ministry also allowed a locally developed anti-viral drug called Virus Suppressing Factor (VSF) to treat COVID-19 patients at the request of Seoul National University Hospital.

hmmmm.
Click to expand...

Archlich said:
I have a feeling this have something to do with the recent political climate between the three countries.
Click to expand...

The recent political climate is certainly a factor in Korea’s decision. Still, the side affects are well known in Japan and many people I speak with here would prefer to avoid taking Avigan given the choice.
 
A French researcher has shown good results with Hydroxychloroquine and others have also had similar good results with it against the virus.
 
Huss said:
The ministry also allowed a locally developed anti-viral drug called Virus Suppressing Factor (VSF) to treat COVID-19 patients at the request of Seoul National University Hospital.

hmmmm.
Click to expand...

VSF is a protein that stimulates immune responses (a cytokine) and has been available for quite some time. It is, unfortunately, also highly immunogenic, and not in a good way - it stimulates antiviral response but a lot of patients are also allergic to, or mount a strong response to the product itself.

f.hayek said:
It's a novel drug they used for the ebola outbreak.
Click to expand...

Favipiravir is not a novel drug, it is part of a large family of products with antiviral activity that are pyrazinecarboxamide derivatives.

jonmanjiro said:
[snip] the side affects are well known in Japan and many people I speak with here would prefer to avoid taking Avigan given the choice.
Click to expand...

Favipiravir is better tolerated than interferon α or ribavirin, but if you are a candidate for these types of treatment non-target effects are probably the least of your concerns.

jonmanjiro said:
Avigan has been around for some time, but hasn’t been approved for general use in Japan [snip]
Click to expand...

It is more likely that the main concerns are about maintaining efficacy and emergence of viral variants with decreased susceptibility during monotherapy. In 2014 it was approved in Japan for use against viral strains that are unresponsive to other registered antivirals.

At any one time pharmaceutical companies (which Fujifilm is one of, whatever it is called) have hundreds or thousands of products marked as candidates, under trial, and at various steps in the proof of concept and registration processes. The vast majority never make it to market for one reason or another. Viruses are very complicated little packets of nucleic acid, and their replication and pathology varies greatly even within closely related groups. A product that works against one virus may not work at all against another, even if the two viruses are of a similar type (e.g. this is a positive sense single-stranded RNA virus) or family (in this case Coronaviridae).

Marty
 
You must log in or register to reply here.
Back
Top Bottom